US2005009012A1PendingUtilityA1
Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
Est. expiryJan 25, 2021(expired)· nominal 20-yr term from priority
C07K 14/005C12N 2770/00022C12N 15/8218C12N 15/8216
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to recombinant viral vectors encoding a transcriptional unit, that encodes a fusion protein, or a foreign protein or a gene of interest to be silenced, which can be expressed in a host. The present invention also relates to the use of these recombinant viral vectors to express a fusion protein, a foreign protein, to silence a gene of interest in a host. The present invention also relates to the use of these recombinant viral vectors to screen a cDNA or genomic library in order to correlate a nucleotide sequence with a phenotypic or biochemical change.
Claims
exact text as granted — not AI-modified1 - 30 . Cancelled.
31 . A viral genome comprising one or more polynucleotide(s), wherein at least one polynucleotide encodes a first promoter operatively linked to a transcriptional unit, wherein the transcription unit encodes a fusion protein, wherein the fusion protein comprises (1) a first viral protein, (2) a second viral protein, and (3) an autoproteolytic peptide, wherein (3) is fused between (1) and (2), wherein at least one polynucleotide encodes a second promoter operatively linked to the ORF encoding a protein of interest.
32 . A viral genome according to claim 31 wherein the viral genome is the viral genome of a multipartite RNA plant virus.
33 . A viral genome according to claim 32 wherein the viral genome is the viral genome of a hordeivirus.
34 . A viral genome according to claim 33 wherein the hordeivirus is a barley stripe mosaic virus.
35 . A viral genome according to claim 34 wherein the first viral protein is γb.
36 . A viral genome according to claim 34 or 35 wherein the second viral protein is βb.
37 . A viral genome according to claim 31 wherein the autoproteolytic peptide comprises the 2A autoproteolytic peptide of a foot and mouth disease virus.
38 . A viral genome according to claim 31 wherein the autoproteolytic peptide comprises the amino acid sequence depicted by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, or SEQ ID NO: 9.
39 . A viral genome according to claim 31 wherein the protein of interest and the fusion protein are encoded on separate polynucleotides.
40 . A viral genome according to claim 31 wherein the protein of interest and the fusion protein are capable of expression in a plant cell.
41 . A viral genome according to claim 40 wherein the plant cell is a monocot plant cell.
42 . A viral genome according to claim 40 wherein the protein of interest and the fusion protein are capable of systemic expression in a plant.
43 . A viral genome according to claim 42 wherein the plant is a monocot plant.
44 - 67 . Cancelled.Join the waitlist — get patent alerts
Track US2005009012A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.